Ciprofloxacin 2 Mg/Ml (50 Ml) Fresenius 2 mg/mL, 2 mg/mL, 2 mg/mL Solution for infusion.
PDF Leaflet Revision Date: 11 October 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Severe and/or complicated infections caused by ciprofloxacin-sensitive bacteria.
Dosage (summary)
Adults: 100-200 mg IV every 12 hours; severe infections: 400 mg IV every 12 hours.
Special Populations
- Elderly patients
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation due to potential fetal harm.
Key Drug Interactions
- QT prolonging drugs
- Tizanidine
- Theophylline
- Methotrexate
- NSAIDs
Contraindications
- Hypersensitivity to ciprofloxacin
- Pregnancy and lactation
- Myasthenia gravis
- History of tendon disorders
- Children under 18 years
Common side effects
- Nausea
- Diarrhea
- Headache
- Dizziness
- Tendinitis
Counselling Points
- Stay well hydrated to prevent crystalluria.
- Avoid direct sunlight due to photosensitivity.
- Report any signs of tendon pain or swelling immediately.
- Monitor blood glucose levels if diabetic.
Serious warnings
- Risk of tendon rupture
- QT prolongation
- Severe skin reactions
- Pseudomembranous colitis
Important Disclaimer
The Ciprofloxacin 2 Mg/Ml (50 Ml) Fresenius 2 mg/mL, 2 mg/mL, 2 mg/mL Solution for infusion. professional information leaflet below is the property of Fresenius Kabi South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
